Gene · 3036
Papers4,320
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,320
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics. | Beilstein J Nanotechnol | 2023 | 37701520 | PubTator, text mining | PubMed |
| Predictive Factors and Clinical Events Associated with Edoxaban Interruption and Heparin Bridging Strategy: EMIT-AF/VTE. | Clin Appl Thromb Hemost | 2023 | 37697813 | PubTator, text mining | PubMed |
| HMCDA: a novel method based on the heterogeneous graph neural network and metapath for circRNA-disease associations prediction. | BMC Bioinformatics | 2023 | 37697297 | PubTator, text mining | PubMed |
| Indonesian first national suicide prevention strategy: key findings from the qualitative situational analysis. | Lancet Reg Health Southeast Asia | 2023 | 37694181 | PubTator, text mining | PubMed |
| Safety and Efficacy of Cryoballoon Pulmonary Vein Isolation and Left Atrial Appendage Closure Combined Procedure and Half-Dose Rivaroxaban After Operation in Elderly Patients with Atrial Fibrillation. | J Multidiscip Healthc | 2023 | 37693855 | PubTator, text mining | PubMed |
| Modern Approaches in Wounds Management. | Polymers (Basel) | 2023 | 37688274 | PubTator, text mining | PubMed |
| Comparative Studies of the Confined Effect of Shear Masonry Walls Made of Autoclaved Aerated Concrete Masonry Units. | Materials (Basel) | 2023 | 37687577 | PubTator, text mining | PubMed |
| Significance of Intra-plaque Hemorrhage for the Development of High-Risk Vulnerable Plaque: Current Understanding from Basic to Clinical Points of View. | Int J Mol Sci | 2023 | 37686106 | PubTator, text mining | PubMed |
| Dissecting pulmonary fibroblasts heterogeneity in lung development, health and diseases. | Heliyon | 2023 | 37674845 | PubTator, text mining | PubMed |
| Research on the biological mechanism and potential application of CEMIP. | Front Immunol | 2023 | 37662915 | PubTator, text mining | PubMed |
| Construction of lncRNA-miRNA-mRNA regulatory network in severe asthmatic bronchial epithelial cells: A bioinformatics study. | Medicine (Baltimore) | 2023 | 37657025 | PubTator, text mining | PubMed |
| Effects of hsa_circ_0074854 on colorectal cancer progression, construction of a circRNA-miRNA-mRNA network, and analysis of immune infiltration. | J Cancer Res Clin Oncol | 2023 | 37644235 | PubTator, text mining | PubMed |
| Is triple antithrombotic therapy a safe option in patients with AF who receive drug-eluting stents?: a review article. | Egypt Heart J | 2023 | 37639078 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals the potential of hyaluronate synthase as therapeutic targets in human tumors. | Heliyon | 2023 | 37636435 | PubTator, text mining | PubMed |
| Machine Learning Approaches for Assessing Risk Factors of Adrenal Insufficiency in Patients Undergoing Immune Checkpoint Inhibitor Therapy. | Pharmaceuticals (Basel) | 2023 | 37631013 | PubTator, text mining | PubMed |
| Effects of Water-Ethanol Extracts from Four Sphagnum Species on Gene Expression of Selected Enzymes in Normal Human Dermal Fibroblasts and Their Antioxidant Properties. | Pharmaceuticals (Basel) | 2023 | 37630991 | PubTator, text mining | PubMed |
| Protective Effects of Lanostane Triterpenoids from Chaga Mushroom in Human Keratinocytes, HaCaT Cells, against Inflammatory and Oxidative Stresses. | Int J Mol Sci | 2023 | 37628993 | PubTator, text mining | PubMed |
| Hemocompatibility of β-Cyclodextrin-Modified (Methacryloyloxy)ethyl Phosphorylcholine Coated Magnetic Nanoparticles. | Biomolecules | 2023 | 37627230 | PubTator, text mining | PubMed |
| Nanomedicine Strategies for Targeting Tumor Stroma. | Cancers (Basel) | 2023 | 37627173 | PubTator, text mining | PubMed |
| Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer. | Biology (Basel) | 2023 | 37626931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3036/papers?page=16